Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors.

The recently crystallized structure of microsomal prostaglandin E2 synthase 1 (mPGES-1) in complex with the inhibitor LVJ (PDB code: 4BPM) offered new structural information for the optimization of the previously identified lead compound 1 (IC50 = 4.16 ± 0.47 μM), which contains the privileged dihydropyrimidin-2-one chemical core. Systematic optimization of 1, through accurate structure-based design, provided compound 4 with a 10-fold improved mPGES-1 inhibitory activity (IC50 = 0.41 ± 0.02 μM). Here we highlight the optimal scaffold decoration pattern of 4 and propose a three-dimensional model for the interaction with this complex trimeric membrane protein. The reported computational insights, together with the accessible one-pot synthetic procedure, stimulate for the generation of further potent dihydropyrimidine-based mPGES-1 inhibitors.

[1]  E. Meuillet,et al.  Identification and development of mPGES-1 inhibitors: where we are at? , 2011, Future medicinal chemistry.

[2]  L. Klareskog,et al.  Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. , 2004, Arthritis and rheumatism.

[3]  C. Kappe.  Biologically active dihydropyrimidones of the Biginelli-type--a literature survey. , 2000, European journal of medicinal chemistry.

[4]  D. Rosenberg,et al.  mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators". , 2010, Biochimie.

[5]  Makoto Murakami,et al.  Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1* , 2004, Journal of Biological Chemistry.

[6]  Ying Yu,et al.  Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. , 2006, The Journal of clinical investigation.

[7]  G. Bifulco,et al.  Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents. , 2011, Journal of medicinal chemistry.

[8]  A. Abdel-Magid.  Prostaglandin e2 synthase-1 inhibitors as potential treatment for osteoarthritis: patent highlight. , 2012, ACS medicinal chemistry letters.

[9]  Patrik Johansson,et al.  Crystal structure of microsomal prostaglandin E2 synthase provides insight into diversity in the MAPEG superfamily , 2013, Proceedings of the National Academy of Sciences.

[10]  B Li,et al.  Creating chemical diversity to target protein kinases. , 2004, Combinatorial chemistry & high throughput screening.

[11]  P. McGettigan,et al.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.

[12]  C. Kappe,et al.  Creating chemical diversity space by scaffold decoration of dihydropyrimidines , 2005 .

[13]  Makoto Murakami,et al.  Potential Role of Microsomal Prostaglandin E Synthase-1 in Tumorigenesis* , 2003, Journal of Biological Chemistry.

[14]  S. T. A. Shah,et al.  Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy , 2014, Crystal growth & design.

[15]  Anders Blomqvist,et al.  Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis , 2003, Nature Neuroscience.

[16]  J. Kremsner,et al.  5-aroyl-3,4-dihydropyrimidin-2-one library generation via automated sequential and parallel microwave-assisted synthesis techniques. , 2007, Journal of combinatorial chemistry.

[17]  J. Lapointe,et al.  Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Ralf Morgenstern,et al.  Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target , 2007, Pharmacological Reviews.

[19]  Makoto Murakami,et al.  Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. , 2005, Journal of biochemistry and molecular biology.

[20]  G. Bifulco,et al.  Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1). , 2014, European journal of medicinal chemistry.